Predict your next investment

HEALTHCARE | Stealth Mode
aggredyne.com

See what CB Insights has to offer

Stage

Series A | Alive

Total Raised

$3M

Last Raised

$3M | 9 yrs ago

About Aggredyne

Aggredyne is a stealth company developing technologies for platelet function testing. The company's Aggredguide is a simple, inexpensive, laser light scattering platelet aggregometer that can provide a full profile of a patients responsiveness to anti-platelet medications.

Aggredyne Headquarter Location

10530 Rockley Road Suite 150

Houston, Texas, 77099,

United States

713-636-5996

Latest Aggredyne News

Insights on the Platelet Aggregation Devices Global Market to 2027 - Featuring Aggredyne, Siemens and Tem Group Among Others - ResearchAndMarkets.com

Jun 25, 2021

Amid the COVID-19 crisis, the global market for Platelet Aggregation Devices estimated at US$277.1 Million in the year 2020, is projected to reach a revised size of US$1 Billion by 2027, growing at a CAGR of 20.9% over the analysis period 2020-2027. Systems, one of the segments analyzed in the report, is projected to record a 20.6% CAGR and reach US$498.8 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Reagents segment is readjusted to a revised 23.1% CAGR for the next 7-year period. The U.S. Market is Estimated at $82.2 Million, While China is Forecast to Grow at 20.1% CAGR The Platelet Aggregation Devices market in the U.S. is estimated at US$82.2 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$179.7 Million by the year 2027 trailing a CAGR of 20.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 18.8% and 18.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 15.4% CAGR. Accessories & Consumables Segment to Record 16.5% CAGR In the global Accessories & Consumables segment, USA, Canada, Japan, China and Europe will drive the 16.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$36.8 Million in the year 2020 will reach a projected size of US$106.1 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$128.4 Million by the year 2027. Select Competitors (Total 46 Featured): Aggredyne, Inc. SENTINEL CH. SpA

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Aggredyne

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Aggredyne is included in 1 Expert Collection, including Medical Devices.

M

Medical Devices

10,537 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

Aggredyne Patents

Aggredyne has filed 2 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/12/2012

10/15/2013

Blood tests, Vascular diseases, Coagulation system, Coagulopathies, Hematology

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

7/12/2012

00/00/0000

Grant Date

10/15/2013

00/00/0000

Title

Subscribe to see more

Related Topics

Blood tests, Vascular diseases, Coagulation system, Coagulopathies, Hematology

Subscribe to see more

Status

Grant

Subscribe to see more

Aggredyne Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Aggredyne Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.